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Molecular Cloning and Analysis
of the Ergopeptine Assembly System
in the Ergot Fungus Claviceps purpurea
-hydroxyethylamide (Figure 1), where D-lysergic acid
is attached to small amino alcohols [4, 5].
Main producers of ergopeptines and the D-lysergic
acid amides are members of the genus Claviceps [6].
Whereas Claviceps purpurea can produce both groups
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Fachgebiet Biochemie the immediate precursor of D-lysergic acid [7, 8]. Other
species, notably Claviceps fusiformis, lack the ability toTechnische Universita¨t Berlin
Franklinstrasse 29 synthesize D-lysergic acid, producing clavine alkaloids
instead, which have still simpler structures [9]. The mainD-10587 Berlin-Charlottenburg
Germany representatives of the clavines represent intermediates
in the ergot alkaloid biosynthesis (for review see [4,
5]). Figure 2 shows the various steps of the ergolene
pathway from the formation of dimethylallyl tryptophanSummary
(DMAT) to the conversion of paspalic acid to D-lysergic
acid. DMAT synthase (DMATS) has been the first enzymeClaviceps purpurea produces the pharmacological im-
of the ergot alkaloid pathway that was purified to homo-portant ergopeptines, a class of cyclol-structured al-
geneity [10, 11]. The DMATS-encoding gene (dmW) waskaloid peptides containing D-lysergic acid. These
the first cloned alkaloid biosynthesis gene from the clav-compounds are assembled from D-lysergic acid and
ine-producing species Claviceps fusiformis [12]. Impor-three different amino acids by the nonribosomal pep-
tantly, an ortholog of dmW named cpd1 was shown to betide synthetase enzymes LPS1 and LPS2. Cloning of
present in ergopeptine-producing Claviceps purpurea,alkaloid biosynthesis genes from C. purpurea has re-
which proved the common biosynthetic origin of thevealed a gene cluster including two NRPS genes,
clavines and the D-lysergic acid-derived group of alka-cpps 1 and cpps 2. Protein sequence data had as-
loids [13].signed earlier cpps1 to encode the trimodular LPS1
Previously, investigations of the assembly of D-lyser-assembling the tripeptide portion of ergopeptines.
gyl tripeptide lactams, the immediate precursor of ergo-Here, we show by transcriptional analysis, targeted
peptines, in C. purpurea have shown that they areinactivation, analysis of disruption mutants, and het-
formed by a large nonribosomal peptide synthetaseerologous expression that cpps 2 encodes the mono-
(NRPS) multienzyme that, during purification, separatedmodular LPS2 responsible for D-lysergic acid activa-
in two enzyme activities [14]. The two enzymes, D-lyser-tion and incorporation into the ergopeptine backbone.
gyl peptide synthetase 1 and 2 (LPS1 and 2) have sizesThe presence of two distinct NRPS subunits catalyzing
of 370 and 140 kDa, respectively. Synthesis starts withformation of ergot peptides is the first example of
binding of D-lysergic acid to LPS2 as thioester followeda fungal NRPS system consisting of different NRPS
by transfer to LPS1, where three successive condensa-subunits.
tions into the D-lysergyl mono-, di-, and tripeptide thio-
ester intermediate take place, with final release of theIntroduction
end product D-lysergyl tripeptide lactam [15]. These
data indicated that LPS1 and LPS2 would contain fourD-lysergic acid (9,10-6-methyl-ergolene-8-carboxylic
modules with individual adenylation (A) domains, pepti-acid) is an important pharmacophore that in its amidated
dyl carrier protein (PCP or T) domains, condensationform exerts useful activities for therapy for the treatment
(C), domains and a putative domain catalyzing releaseof migraine, hypertension, or prolactine disorders [1, 2].
of the lactam product, presumably a thioesterase (Te)The specific effects of the various amides of D-lysergic
domain [16]. While LPS1 would harbor the three aminoacid depend on the amide substituents which confer to
acid modules, LPS2 would represent the D-lysergic acidD-lysergic acid structural similarity to adrenaline, sero-
module (Figure 2).tonine, or dopamine, causing agonist or antagonist be-
Sequencing the flanking regions of the recently clonedhavior against the corresponding neurotransmitter fami-
DMAT synthase gene cpd1 from C. purpurea led to thelies [3]. Most prominent among the D-lysergic amides
identification of further genes most probably involvedare the ergopeptines, in which the amide component is
in ergoline ring synthesis (Figure 3). Importantly, down-a tripeptide chain in the modified form of a bicyclic
stream to cpd1 the gene encoding the trimodular en-cyclol-lactam structure (Figure 1). Simpler D-lysergic
zyme LPS1, cpps1, was identified, indicating the pres-acid derivatives are ergometrine or D-lysergic acid
ence of an ergot alkaloid gene cluster [17]. This finding
suggested that further chromosome walking on the
*Correspondence: ullrich.keller@tu-berlin.de (U.K.), tudzyns@uni- flanking regions of cpd1 would disclose the gene of
muenster.de (P.T)
LPS2, for which protein sequence data were not avail-3 These authors contributed equally to this work.
able. In this report, we describe the genetic organization4 Present address: ActinoDrug Pharmaceuticals GmbH, Neuendorf-
strasse 24a, D-16761 Hennigsdorf, Germany. of an as yet unidentified region of the ergot alkaloid
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Figure 1. Natural D-Lysergic Acid Deriva-
tives
(A) General structure of ergopeptines [R1 
CH3, R2  CH2C6H5, ergotamine; R1 
CH(CH3)2, R2  CH2CH(CH3)2, ergocryp-
tine; R1CH3, R2CH2CH(CH3)2 ergosine].
(B) Structure of D-lysergyl-tripeptide lactams,
the immediate precursors of ergopeptines.
(C and D) (C), D-lysergyl--hydroxyethylam-
ide; (D), ergometrine (syn. ergobasine).
cluster with a novel NRPS gene cpps2, which by genetic In order to identify the gene of LPS2, which from the
biochemical data should be composed at least of an Aand biochemical characterization was shown to encode
LPS2. and a PCP domain, a chromosome walking was per-
formed downstream of the gene cpox2. During this, sev-
eral ORFs could be detected [4]; sequence analyses ledResults
to the identification of a putative P450 mono-oxygenase
gene (cpP450-1), a putative catalase gene (cpcat2), aSequence Analysis of LPS1, Prediction
of the Structure of LPS2, and Cloning of cpps 2 putative oxidase gene (cpox3), and, interestingly enough,
a gene showing significant homology to fungal NRPS,Detailed analysis of the amino acid sequence deduced
from the gene sequence of cpps1 had shown that LPS1, which was named cpps2 (Figure 3A). This gene (Gen-
Bank accession number AJ439610) has a coding se-as expected from previous biochemical work, contains
three A and three PCP domains (also called T domains) quence of 3924 bp interrupted by an intron of 65 bp,
leading to a putative protein of 1308 amino acids with(Figure 3A). However, the sequence also revealed that
LPS1 has only two C domains, i.e., in module 2 and a calculated Mr of 140 kDa.
Since cpps2, according to the size of the encodedmodule 3. No such C domain was seen aminoterminally
to the first A domain in module 1. This suggested that protein and its vicinity to other ergot alkaloid biosynthe-
sis genes in C. purpurea strain P1, was a possible candi-the C domain for formation of the peptide bond between
D-lysergic acid and the first amino acid of the cyclol date gene for LPS2, its deduced amino acid sequence
was analyzed in respect to the overall structure andpeptide chain was located either on LPS2 or on another
as yet unknown protein component of the LPS multien- domain composition. Alignments of Cpps2 with various
NRPS sequences in the database revealed that it iszyme complex. Another interesting feature of the de-
duced amino acid sequence of cpps1 is that LPS1 has a composed of four domains (Figure 3A). An A domain in
the protein sequence commences at a distance of 280carboxy-terminal domain with no similarity to the typical
release domain of NRPS, such as the thioesterase (Te) amino acids from the amino-terminal end. The A domain
is followed by a typical PCP domain (T) of about 100domain [18, 19]. Instead, this domain has some similarity
to C domains as well as to heterocyclization domains amino acid residues, whereas in the carboxy-terminal
portion of Cpps2 a domain of 500 amino acids is present,(Cy domains) of NRPS [16]. However, it is 70 amino
acids shorter than the typical C and Cy domains and showing high similarity to the regular C domains of pep-
tide synthetases. Interestingly, the amino-terminal do-shows significant differences in the signature sequences
(C1 to C6 and Cy1 to Cy6, respectively [16]) of C and main of Cpps2 with about 280 amino acids has no simi-
larity to known proteins except for a stretch of 100Cy domains. In particular, the C3 motif of the LPS1
carboxy-terminal domain, Q-R-A-Q-D-G-V-S, differs amino acids between the amino acid positions 40 to
about 140 with weak homology to the carboxy-terminalfrom both the C3 consensus H-H-x-I-S-D-G-W and Cy3
consensus D-x-x-x-x-D-x-x-S of the C and Cy domains, half of C domains. Based on these findings, cpps2 was
considered the gene of LPS2, particularly because ofrespectively (Figure 3B). The double H of the C3 motif
as well as the first D of the Cy3 motif are missing, which the presence of the carboxy-terminal C domain that
exactly matches what would be expected from the bio-suggests a different mechanism of this domain. There-
fore, this domain cannot be regarded as a regular NRPS chemical investigations of the LPS system and the struc-
ture and size of LPS1.C domain. In view of the release of the D-lysergyl tripep-
tide chain from LPS1 as an acyl-diketopiperazine, it is
most likely involved in product release catalyzing the Expression Analysis of cpps2 in C. purpurea
In order to show the significance of Cpps2 for D-lysergyllactam formation step from D-lysergyl tripeptidyl-PCP
thioester. We designated this domain as the cyclization peptide synthesis in C. purpurea, Northern blot analyses
of total RNA using the cpps2 gene were performed. Itdomain (Cyc domain)
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Figure 2. The Ergoline Ring System Pathway
Steps leading from dimethylallylpyrophos-
phate (DMAPP) and tryptophan to D-lysergic
acid [5] and assembly of D-lysergyltripeptide
in the LPS system [15].
is known that ergot alkaloid synthesis is regulated by Functional Analysis of cpps2
To show the direct involvement of cpps2 in ergopeptinethe presence of phosphate and that repression by high
phosphate concentrations can be relieved by trypto- assembly, gene inactivation was performed by a gene
replacement approach: cpps2 was interrupted by aphan, an inducer of ergot alkaloid synthesis [20, 21].
Indeed, we could show recently that several genes of phleomycin-resistance cassette as shown in Figure 5.
From the 5 and 3 genomic region of cpps2, two frag-the ergot alkaloid cluster (Figure 3A), including the gene
encoding DMATS (cpd1) and the oxidase genes (cpox1, ments were cloned upstream and downstream, respec-
tively, of the phleomycin-resistance cassette of vectorcpP450-1), are coregulated in terms of their dependence
of expression on the phosphate concentrations in the pAN8-1UM. The ApaI/BamHI fragment carrying the
whole replacement construct was used to transform C.medium, which confirms their potential role in alkaloid
biosynthesis (Y. Lu¨bbe, T.C., and P.T., unpublished purpurea strain P1. Phleomycin-resistant transformants
obtained were individually checked for the presence ofdata). Expression analysis of the cpps2 gene therefore
was performed with mycelia grown under low- and high- the replacement fragment in the genomes (generated
by double crossover events) by PCR as described inphosphate conditions (see Experimental Procedures).
The data presented in Figure 4 clearly show a transcript Experimental Procedures (Figure 5A). From a total of 98
primary transformants, 26 showed the correct “diagnos-of cpps2 of the expected size which is upregulated un-
der low phosphate condition, comparable to the behav- tic” PCR fragments of 1692 bp (generated with primers
p2HUX and P2HLX) and 1829 bp (primers P2HUCP/ior of cpd1 and cpps1 as controls. This regulation pat-
tern correlated with alkaloid production of the cultures P2HLCP). This is a rather high frequency (27%) when
compared to the previous values of 1%–2% observed in(data not shown).
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Figure 3. Map of the Ergot Alkaloid Biosynthesis Gene Cluster in C. purpurea Strain P1 and Section of an Amino Acid Alignment of Cyc, C,
and Cy Domain Regions of NRPS
(A) Location of cpps1 and cpps2 in the ergot alkaloid biosynthesis gene cluster and the deduced structures of LPS 1 and LPS 2. Cpcat2,
cpP450, cpox3, and cpps2 have been sequenced during this study, whereas the other genes were sequenced previously [17]. The narrow
white boxes in cpps1 and 2 denote the introns in these genes.
(B) Conserved motif HHxxxDxxS from regular C domains of LPS1, the corresponding Cyc domain motif QRAQFDxxS from the carboxy-terminal
domain of LPS1, and the corresponding Cy motif DxxxxDxxS from heterocyclization domains of NRPS. Sequences are from the two internal
C domains of LPS1 (GenBank accession number CAB39315), the Cy domains of pyochelin synthetase (PchF1) (GenBank AAD55801), of
bleomycin synthetase (BlmIV) (GenBank AAG02364), and from the Cyc domain of LPS1 (GenBank CAB39315).
knockout experiments using the pathogenic field isolate
Claviceps purpurea 20.1 [17, 22, 23]. The identity of the
PCR fragments was confirmed by sequence analysis
(data not shown). It is known that C. purpurea P1 and
its parent strain ATCC 20102 are polykaryotic, harboring
more than 10 nuclei per cell compartment [24]. From
this, it is clear that single integration events always lead
to heterokaryons. In fact, all of our positive primary
transformants also showed the wild-type fragment. To
obtain homokaryotic segregants, a positive trans-
formant was propagated from which single-cell units
had to be prepared by protoplast subculturing and hy-
phal tip isolation because of the inability of P1 to pro-
duce conidia (see Experimental Procedures). From a
total of 600 subcultures thus generated, one homokary-
otic mutant could finally be isolated. This transformant
was lacking the wild-type PCR fragment containing the
diagnostic band only (shown for the left flank of disrup-
tion construct in Figure 5B); it was named cpps2-1.
Southern analyses confirmed the PCR data (Figure 5C)
Final proof for the inactivation of cpps2 in the cpps2-1Figure 4. Northern Analysis of cpps2 in High- and Low-Phosphate
mutant came from Northern analysis which showed thatConditions and Coregulation of Other Genes of the Ergot Alkaloid
Cluster no cpps2 transcript could be detected in the mutant
Wild-type mycelia were grown under low- and high-phosphate con- under conditions that stimulate expression of cpps2 in
ditions (see Experimental Procedures), RNA was extracted and, after strain P1 (Figure 5D).
separation in a agarose gel, was blotted on a nylon membrane.
Probes used for hybridization were as follows: 4.0 kb HindIII frag-
ment (cpps1, 17), a 0.8 kb SalI fragment (cpd1, 17), and a 3.5 kb
Analysis of the Alkaloid Spectrum of cpps2-1SalI fragment (cpps2, Figure 3). A plus sign denotes RNA under low-
Since strain cpps2-1 represents a bona fide deletionphosphate conditions, and a minus sign indicates high-phosphate
conditions mutant, it was analyzed for its ability to form ergopep-
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Figure 5. Functional Analysis of cpps2
(A) Gene replacement strategy: the design of
the replacement fragment (upper part) and
the genomic situation after a successful gene
replacement by double crossover (lower part)
are presented. Primer binding sites are indi-
cated by arrow heads (for details see Experi-
mental Procedures). The narrow white box
indicates the intron in cpps2.
(B) PCR analysis of a cpps2 mutant and the
wild-type strain (P1) using diagnostic primers
for the left flank (HI) and wild-type primers
(WT). Left panel, wild-type primers; right
panel, with “left flank” primers. For details,
see Experimental Procedures.
(C) Southern analysis of a replacement trans-
formant: genomic DNA of the wild strain and
mutant cpps2-1 was digested with ClaI,
transferred to a nylon membrane, and hybrid-
ized to a 3.5 kb SalI fragment of the cpps2
region (see Figure 3). The labels a, b, and c
denote the hybridizing ClaI fragments ex-
pected to be present in cpps2-1 and wild-
type P1, respectively.
(D) Northern analysis: total RNA from wild-
type and mutant cpps2-1 was extracted
from mycelia grown under alkaloid produc-
tion conditions, blotted on a nylon membrane,
and hybridized to the cpps2 probe (see C).
tines and other alkaloids. Cultivation of the mutant, Enzymatic Analysis of cpps2-1
Protein fractions of the cpps2-1 mutant along withalong with an ectopic integration mutant and the recipi-
ent strain P1 as controls, was in standard alkaloid pro- protein fractions from the parent strain P1 were tested
for the presence of LPS1 and LPS2 by measuringduction medium with limiting phosphate concentrations.
Analysis of the individual components of the alkaloid the ability to form enzyme thioester with 14C-valine or
14C-phenylalanine and 3H-dihydrolysergic acid, respec-mixtures was performed by TLC, HPLC, or electrospray
mass spectrometry. Figure 6 shows that strain P1 pro- tively. To this end, protein from extracts of broken cells
of the two strains was fractionated by ammonium sulfateduces ergotamine, ergocryptine, and ergosine as main
alkaloids. Moreover, from the clavines, elymoclavine precipitation and subjected to gel filtration on Ultrogel
AcA34. Testing fractions from the gel filtrations fromwas detected in significant amounts (data not shown).
By contrast, the cpps2-1 mutant did not produce any both strain P1 and the mutant gave a peak of valine
or phenylalanine thioester formation shortly behind theergopeptine on solid or in liquid medium but accumu-
lated D-lysergic acid, which is absent from strain P1, void volume of the column, which represented LPS1
activity (Figure 7). The peak of activity of dihydrolysergylindicating accumulation of that compound due to
blockage of ergopeptine synthesis. Radioisotope label- enzyme thioester of LPS2 in strain P1 could be detected
separately from that of LPS1 in the fractionation rangeing of ergopeptines using radioactive amino acids in
short-term incubations of washed mycelium and TLC of about Mr 150,000. In SDS-gel electrophoretic separa-
tions of the fraction containing dihydrolysergic thioester-separations of the radioactive alkaloid mixtures in P1
or the cpps2-1 mutant confirmed these results (data forming activity, a 140 kDa band could be visualized
by autofluorography after incubation with radioactivenot shown). The fact that strain cpps2-1 accumulated
D-lysergic acid instead of forming ergopeptines clearly dihydrolysergic acid and ATP (Figure 7) . By contrast, no
dihydrolysergic acid thioester formation was detected inindicated that ergoline ring synthesis was unaffected by
gene disruption in cpps2 (Figure 6). protein extracts of the cpps2-1 mutant, which con-
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Figure 6. Mass Spectrometric Analysis of Alkaloid Extracts from Strain C. purpurea Strain P1 and the cpps2 Mutant
Extracts from each strain grown on solid or liquid media were subjected to electrospray mass spectrometry as described in Experimental
Procedures.
(A and B) HPLC separations of extracts from strain P1 and the cpps2 mutant, respectively.
(C–E) Mass peaks of the indicated peaks from (A). (C), ergosin m/z  548 [M  H]; (D), ergotamin m/z  582 [M  H]; (E), ergocryptin m/z 
576 [M H]).
(F) Mass peaks of compounds accumulated in (B) (D-lysergic acid m/z  269 [M  H]).
tained solely LPS1 at a level comparable to strain P1 sion protein in E. coli. After verification of the intron of
cpps2 by RT-PCR, which revealed the correctness of(Figure 7). This represents good evidence that cpps 2
is encoding LPS2. the intron-exon junctions inferred from analysis of the
genomic DNA sequence (data not shown), a cDNA was
constructed via PCR amplification of fragments of theHeterologous Expression of cpps2 in E. coli
To characterize the gene product of cpps2 further, exon-encoding regions of cpps2, allowing the two exons
to join via an EcoRV restriction site (see Experimentalcpps2 was engineered for expression as a hexaHis fu-
The Ergopeptine Assembly System in C. purpurea
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Figure 7. Comparative Functional Analysis of LPS2 in Protein Fractions from C. purpurea Strains P1 and cpps2-1 and from E. coli
(A) Analysis of protein extracts of C. purpurea strains P1, cpps2 mutant, and E. coli carrying plasmid cpps2_pNG5 (cpps2) for the presence
of LPS2 activity. I and II show gel filtration on Ultrogel AcA 34 of an ammonium sulfate-fractionated protein extract from C. purpurea strain
P1 (I) producing ergopeptines and C. purpurea cpps2 (II). Each fraction was assayed for the presence of LPS1 and LPS2 by the thioester
formation assay with 14C-phenylalanine (or 14C-valine) (circles) and 3H-dihydrolysergic acid (squares), respectively. Protein is denoted by
diamonds. The inset in I shows an autofluorograph of an SDS polyacrylamide gelelectrophoretic separation of the peak fraction containing
LPS2 activity after incubation enzyme with 3H-dihydrolysergic acid and ATP. No LPS2 activity is present in C. purpurea cpps2. III shows
gel filtration on Superdex 200 of recombinant LPS2-32 partially purified from E. coli after expression from plasmid (cpps2_pNG5). Fractions
were tested for the ATP-pyrophosphate exchange dependent on D-lysergic acid (squares); protein is denoted by diamonds.
(B) Aligment of substrate specificity determining amino acid residues in binding pockets of LPS2 and several NRPS adenylation domains with
known substrates. Shown are the extracted residues from the LPS2 A domain and the A domains of NRPS A domains and Aryl-AMP-ligases
(arylcarboxylate activating enzymes). D-LSA, D-lysergic acid. Numbers refer to the corresponding residues in the PheA domain of gramicidin
synthetase 1 [34, 35]. CepB, chloroeremomycin synthetase (GenBank accession number CAA11795); CdaI, CDA peptide synthetase I (GenBank
CAB38518); SafAI, saframycin Mx1 synthease A (GenBank AAC44129); SnbA, pristinamycin synthetase I (GenBank CAA67140); YbtE, yersinia-
bactin synthetase (GenBank AAC69591); ACMS I, actinomycin synthetase I (GenBank AAD30111); EntE, enterobactin synthetase (GenBank
AAN79156); HPG, dihydroxyphenylglycine; 3h4mPhe, 3-hydroxy-4-methyl-phenylalanine; HPic, 3-hydroxypicolinic acid; 4-MHA, 4-methyl-3-
hydroxyanthranilic acid; DHB, 2,3-dihydroxybenzoic acid, Sal, salicylic acid.
Procedures). Since the intron is located in the region Two constructs were prepared on the basis of expres-
sion vectors pQE 32 (LPS2-32) and pQE 70 (LPS2-70)of the gene encoding the amino-terminal domain, the
resultant change of the amino acid sequence (LF→DI) with a hexaHis-encoding sequence at the 5 and the
3 ends, respectively. Expression was in E. coli M15.was not expected to disturb the activity of the A domain.
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Attempts to purify the soluble fraction of either enzyme time a fungal NRPS system consisting of several sub-
units. The systems known previously have always con-on Ni-NTA matrix failed due to lack of binding to the
affinity matrix. Using the D-lysergic acid-dependent sisted of one polypeptide chain [28].
The analyses showed that LPS2 is a stand-alone initia-ATP-pyrophosphate exchange as assay, LPS2-32 was
partially purified by a classical purification protocol [25] tion module analogous to bacterial NRPS systems such
as the phenylalanine recruiting module for initiation ofinvolving ammonium sulfate precipitation and several
steps of gel filtration and anion exchange chromatogra- gramicidin S or tyrocidine in Bacillus brevis [16] or the
aryl carboxylic acid recruiting composite EntE/EntB inphy (Figure 7). In each separation step, there was a peak
of D-lysergic acid activation which was absent from the the initiation of siderophore synthesis in E. coli, Yersinia
pestis, or in Vibrio cholerae [29]. Such initiation modulesnontransformed strain (data not shown). Like the native
LPS2 enzyme, LPS2-32 did not activate any of the amino or units consist at least of an A and a PCP domain,
and they normally interact in trans with their cognate Cacids present in the peptide chain of D-lysergyl peptide
lactam or tryptophan (which, like D-lysergic acid, con- domain located on the subunit harboring the next mod-
ule of the biosynthetic sequence catalyzing the elonga-tains an indole ring as characteristic structural element).
Attempts to demonstrate dihydrolysergic acid enzyme- tion step following activation of the starter residue. In
bacterial NRPS systems, even such C domains can oc-thioester formation with LPS2-32 failed. Most probably,
LPS2-32 does not contain a 4-phosphopantetheine co- cur as autonomous proteins, e.g., the stand-alone VibH,
which condenses enzyme thioester-activated aryl car-factor necessary for covalent binding of the substrate
as thioester. Incubations of the protein with two different boxylic acids with a free amine during the biosynthesis
of the siderophore vibriobactin in V. cholerae [30]. How-4-phosphopantheteine transferases such as Sfp [26] or
OrfC [27] in the presence or absence of coenzyme A ever, the analysis of the deduced amino acid sequence
of cpps2 revealed that in contrast to the integral or, evenwith 3H-dihydrolysergic acid did not show any increase
in bound radioactivity. more, to the composite bacterial initiation modules,
LPS2, in addition to its A and PCP domain, does contain
an integral “regular” C domain at its carboxyl terminus in
Discussion the arrangement (A-PCP-C). From the deduced domain
arrangement and calculated size (140 kDa, 1308 aa), the
The results presented here show that the ergot alkaloid cpps2 gene product meets all criteria required to fulfil
gene cluster from Claviceps purpurea harbors two NRPS the role of LPS2 [14]. In particular, the presence of the
genes, cpps1 and cpps2. Cpps1 had been identified C domain at the carboxyl terminus of LPS2 readily points
earlier as the gene encoding the nonribosomal peptide to a role attributed to the C domain originally believed
synthetase LPS1 (370 kDa), which is responsible for to reside at the amino-terminal end of LPS1 necessary
the assembly of the tripeptide portion of the D-lysergyl for condensation of D-lysergic acid with the amino acid
tripeptides in C. purpurea. Detailed analysis of the de- activated by the first module of LPS1. The domain ar-
duced amino acid sequence of LPS1 showed that it has rangement (A-PCP-C) of the cpps2 gene product is
a domain arrangement (A-PCP-C-A-PCP-C-A-Cyc) with nonetheless unusual in NRPS systems, because C do-
three A and three PCP domains, two C-domains, and a mains are usually cis-acting domains in respect to their
terminal domain called the Cyc domain. The Cyc domain downstream A and PCP domains [19]. This may be a
has limited similarity to both C and Cy domains of NRPS consequence of the observed substrate specificity of C
but is most different in the so-called C3 and Cy3 motif domains, which has been reported to be high for the
of the latter domains (Figure 3B), suggesting a special substrate bound to the downstream PCP-bound sub-
mechanism in acyl diketopiperazine formation, which is strate and low for the substrate from the upstream mod-
the final step of D-lysergyl peptide lactam synthesis ule [32]. Accordingly, elongation subunits in NRPS very
(Figure 1). Formation of peptide lactam formation re- often commence at their amino-terminal ends with a C
quires abstraction of a proton from the amide nitrogen domain, which reflects the observed functional intimacy
of the peptide bond between the first and second amino between C domains and their downstream A domains. In
acid in the D-lysergyl peptide intermediate, nucleophilic the LPS system, the D-lysergic acid amidating C domain
attack of the resulting enimine electron pair onto the would therefore act in trans to its dowstream A domain.
carbonyl C of the thioester group, and cyclization. Pro- The significance of the carboxy-terminal trans-acting C
ton abstraction from a peptide nitrogen group appears domain of LPS2 is not clear. Whether it is a mere excep-
to rely on a mechanistic basis different from that of tion to the rule or may have significance in the light of
abstraction from amino groups of amino acids catalyzed the very high substrate specificity of LPS2 for D-lysergic
by regular C domains or by thioesterase domains [31]. acid [14] remains to be seen in the future, when swap-
The analysis of LPS1 also revealed that, unexpectedly, ping of that C domain between LPS2 and LPS1 will
it was missing an amino-terminal C domain in the first become possible. The only known example of a stand-
module. This led us to conclude that this C domain is alone module having a carboxy-terminal C domain is
located on another protein such as LPS2, the d-lysergic the monomodular VibF of vibriobactin synthesis in Vibrio
acid module. In the course of this study, cpps2 was then cholerae [33]. Like Cpps2, VibF (domain arrangement
definitely shown by genetic and biochemical criteria to Cy1-Cy2-A-C1-PCP-C2) has the carboxy-terminal C do-
encode LPS2. This also proved that LPS1 and LPS2 are main (termed C2), which is the only catalytically active
distinct proteins and not the degradation products of a one (in contrast to C1) in acylating a free small diamine,
larger NRPS multienzyme consisting of a single poly- dihydroxybenzoyl-norspermidine, at both its primary
and secondary amino groups with a small peptide gener-peptide chain. These findings demonstrate for the first
The Ergopeptine Assembly System in C. purpurea
1289
ated by the Cy1-Cy2-A-(C1)-PCP domain assembly up- drophobic amino acids (best 50% score with the
p-hydroxyphenylglycine-activating module of chloroer-stream of C2. However, the difference to LPS2 lies in
the fact that VibF acts in trans acylating a free substrate, emomycin synthetase [36]). Furthermore, no convincing
similarity of the LPS2 A pocket residues was seen withwhereas LPS2 acts in trans acylating the amino acid
covalently tethered to the first module of LPS1, which the corresponding residues characterizing the A domain
pockets of aryl-AMP ligases [37]. Strikingly, there wasmay require specific protein-protein interactions. Com-
parison of the C domain sequence of Cpps2 (LPS2) with also no evident similarity with the specificity-determin-
ing residues of tryptophan-activating A domains of vari-the internal C domain sequences of LPS1 gave no hint
for characteristic peptide sequences possibly involved ous NRPS, suggesting that the indole portion may not
play a role in the recognition of D-lysergic acid by LPS2in protein-protein interactions (data not shown).
Direct and unequivocal evidence for the identity of (Figure 7B). Since the best matches were observed with
the pocket residues of A domains catalyzing hydropho-Cpps2 and LPS2 was obtained by gene replacement of
cpps2 in the C. purpurea genome by a phleomycin- bic amino acids, it may be suggested that the LPS2 A
domain substrate binding pocket resembles typical Aresistance cassette that created phenotype accumulat-
ing D-lysergic acid instead of ergotamine and other er- domains binding amino acids (e.g., the ones of LPS1)
rather than the binding pockets of A domains activatinggopeptines. This clearly indicated a blockade in the
assembly of D-lysergyl tripeptide lactam. Comparative aryl carboxylic acids. Possibly, therefore, ring C and D
of D-lysergic acid, which have no aromatic character,enzymatic studies of protein extracts derived from the
cpps2 mutant and its parent strain P1 showed that the would contribute to recognition by the A domain (Figure
1). The indole ring system of D-lysergic (ring A and B)ergopeptine-producing strain P contained both LPS1
and LPS2, whereas extracts from the cpps2 mutant as recognition element would play a minor role, being
too distant from the carboxyl and the methylamino groupwere devoid of any LPS2-related activity (Figure 7).
Moreover, Northern analysis of RNA obtained from cul- in ring D. Unfortunately, no substrate analogs of D-lyser-
gic acid were available to test this hypothesis, and onetures grown in low and high concentrations of phos-
phate indicated the same regulation pattern for cpps2 must therefore await structure data of the LPS2 A do-
main in the future that will give insight into the molecularas for cpps1 and other genes located in the gene cluster
that show growth-linked repression by phosphate (e.g., details of D-lysergic acid recognition and binding.
The fact that LPS1 and 2 are distinct enzymes raisesthe DMAT synthase gene cpd1) concomitantly with low-
ered alkaloid production in cultures of Claviceps sp. the question of whether this exception to the hitherto
described fungal NRPS systems is of vital importance[20] (Y. Lu¨bbe, T.C., and P.T., unpublished data). These
findings indicate a clear involvement of the gene product for Claviceps purpurea and ergot fungi in general. It is
known that D-lysergic acid is constituent not only ofof cpps2 in D-lysergyl peptide assembly and also core-
gulation with expression of cpps1 by phosphate. This ergopeptines but also of the simpler D-lysergic acid
peptides and amides such as ergosecaline or ergomet-is particularly important in view of the fact that the known
fungal NRPS consist of single polypeptide chains, which rine and D-lysergic acid -hydroxyethylamide, respec-
tively [4]. A number of C. purpurea strains can producewarrants equimolarity of the various modules in these
multienzymes. In order to warrant such conditions of both ergopeptines and ergometrine simultaneously [6],
which indicates the presence in one strain of two differ-balanced levels of the different modules for the LPS
system, coordinate transcription of cpps1 and cpps2 is ent biosynthesis systems, both using D-lysergic acid as
substrate. Ergometrine is derived from D-lysergyl ala-obviously necessary.
Final proof for the identity of Cpps2 with LPS came nine [38], for which a D-lysergic acid module like LPS2
and an alanine module with an additional releasing do-from expression experiments with cpps2 cDNA in E. coli
which yielded a protein of the expected size of 140 main would be required. In strains producing both ergo-
peptines and simple D-lysergic acid amides, LPS2 couldkDa that specifically catalyzed the D-lysergic acid- (and
dihydrolysergic acid-)dependent ATP-pyrophosphate play a central role by interacting either with LPS1-type
enzymes or alanine modules in some kind of naturalexchange (Figure 7). Like wild-type enzyme, the enzyme
did not activate any of the amino acids of ergopeptines combinatorial biosynthesis. This could at least partly
explain why the D-lysergic acid module stands aloneor tryptophan. In contrast to its ability to catalyze the
ATP-pyrophosphate exchange dependent on D-lysergic and is not part of a multimodular NRPS, because its
acid, the LPS2 from E. coli did not catalyze the enzyme- standing alone would easily permit its integration and
thioester formation with dihydrolysergic acid, as did the participation in different enzyme systems. Moreover, the
wild-type enzyme. We argue that this is probably due presence or absence of such genes of LPS2- and LPS1-
to the lack of 4-phosphopantetheine cofactor. Possibly, like enzymes may facilitate the understanding of the
the LPS2-apoenzyme may be a specific substrate for a basis of diversity in product formation in various species
Ppant transferase from the ergot fungus C. purpurea of ergot fungi.
that is not yet known.
The inspection of the specificity-determining region
Significanceof the A domain (amino acid binding pocket) of LPS2
by comparison with the amino acid pocket of the PheA
The results presented here demonstrate unequivocallydomain of tyrocidine synthetase I according to pre-
that alkaloid peptides are assembled by an NRPS sys-viously published procedures [34, 35] indicated unique-
tem consisting of two distinct multienzymes (LPS1 andness of the D-lysergic acid binding pocket (Figure 7B).
It showed similarity to some A domains activating hy- LPS2) harboring three and one modules, respectively.
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were acquired from m/z  100 to 700. For spectra acquisition, aThis is in contrast to known fungal NRPS systems
total of 10 scans were summarized. The HPLC system consisted ofwhich harbor all their modules on one polypeptide
a HP series 1100 solvent delivery system (Waldbronn, Germany).chain. Cloning of the ergot alkaloid gene cluster of C.
HPLC separation was carried out on a C18 column (100  2 mm,
purpurea revealed the presence of the corresponding phenomenex LUNA 3) at a flow rate of 300 l/min, operated at
genes, cpps1 and cpps2, in an alkaloid biosynthesis 30	C. Compounds were eluted using a gradient (A  H2O, 0.05%
formic acid, B  acetonitril, 10 to 100% B in 30 min).gene cluster. Analysis of cpps2 along with cpps1 by
transcription analysis and targeted inactivation in C.
Nucleic Acid Extraction and Analysispurpurea revealed coordinate expression with other
Standard recombination DNA methods were performed accordinggenes in the cluster upon induction of alkaloid synthe-
to [41]. The plasmids used for subcloning fragments were pUC19,sis in cultures. Enzymatic analysis of a cpps2 mutant pTZ18 U (Amersham Pharmacia Biotech), or pSP72 (Promega). Ex-
and of the heterologously expressed protein gave pression plasmids were pQE32 and pQE70 (Qiagen). Echerichia coli
clear evidence that cpps2 encodes LPS2, the D-lyser- strains used for cloning were TOP10F (Invitrogen) and, for expres-
sion, M15 (Qiagen). All of these strains were grown according togic acid-activating module which, together with LPS1,
standard protocols. Extraction of genomic DNA and of RNA, South-assembles the D-lysergyl tripeptide precursors of er-
ern and Northern analyses, and DNA sequencing were performedgopeptines. The existence of LPS2 as a monomodular
as described [23]. Sequence comparisons, multiple sequence align-enzyme points to its role in other D-lysergyl peptide ments, and identity scores were computed with Megalign (DNASTAR),
assemblies in ergot fungi such as the D-lysergyl-alk- BESTFIT (HUSAR), or CLUSTAL X [42]. For PCR analyses, REDTaq
ylamides which may determine the spectrum of prod- (Sigma-Aldrich), Bio Therm (Genecraft), and Vent DNA polymerase
(BioLabs) were used according to the manufacturer’s instructions.ucts formed. Thus, the observed accumulation of
D-lysergic acid in cpps2 mutants points to the possi-
Cloning of cpps2 and Generation of a Replacement Vectorbility that the ergot alkaloid gene cluster in different
A genomic 
EMBL3 library of C. purpurea strain P1 (1029/N5 [17])ergot fungi may differ from each other by the presence
was probed with a 1.8 kb fragment of the religation plasmid
or absence of genes involved in steps of ergoline ring p25S7ReHindIII containing the 3 end of the cpps2 gene using the
synthesis or peptide assemblies. The availability of the plaque filter hybridization technique [41]). Of 69,000 screened
independent D-lysergic acid module LPS2 and its gene plaques, 4 hybridizing 
 clones were obtained and purified. One of
them, 
63, was digested with several restriction enzymes (BamHI,cpps2 opens new and interesting perspectives for the
EcoRI, HindIII, SalI, and XbaI), and the resulting fragments wereunderstanding of the biosynthesis of the wide spec-
further cloned into the pUC19 cloning vector. The overlapping sub-trum of naturally occurring D-lysergic acid amides and
clones were sequenced to obtain the complete coding sequence
for design of new pharmacological lysergic acid deriv- of cpps2. For construction of the cpps2 replacement vector, a 1.35
atives by combinatorial biosynthesis. kb ClaI/Pst fragment of plasmid p63SmaI6,4 (containing the whole
coding region of cpps2) was subcloned into the pAN81 UM [43] to
Experimental Procedures yield pcpps2. Digestion with ApaI and NotI gained a 4.6 kb frag-
ment including the 5 region of cpps2 and the phleomycin-resistance
Strains and Cultures cassette (phle). The 3 region of cpps2 located between 2589 bp to
C. purpurea strain P1 (1029/N5) was described previously [21]. It 3794 bp (respective to the start codon) was amplified by PCR using
produces mainly ergotamine, with minor amounts of ergocryptine primers PS2U and PS2L and cloned into the PCR2.1 TOPO vector
and ergosine. Maintenance and culture conditions for strain P1 and to yield pcpps2. This plasmid construction was linearized with
the replacement mutant cpps2-1 (see Results) were as described ApaI and NotI and ligated with the ApaI/NotI fragment of pcpps2,
[14, 17]. resulting in the circular replacement vector pcpps2. The replace-
ment fragment was excised with ApaI/BamHI and used to transform
Chemicals and Radiochemicals C. purpurea (see Figure 3).
[9,10-3H]-9,10-dihydroergocryptine (17.5 Ci/mmol) was from Hart-
mann Analytics, Braunschweig (Germany). L-[U-14C]-phenylalanine Transformation of C. purpurea and Molecular
(443 mCi/mmol), L-[U-14C]-alanine (148 mCi/mmol), and L-[U-14C]- Characterization of Transformants
valine (260 mCi/mmol) were from Amersham International. [9,10-3H]- Transformation of C. purpurea strain P1 was performed as follows:
9,10-dihydrolysergic acid was prepared from [9,10-3H]-9,10-dihy- a mycelial supension of strain P1 was spread on the surface of
droergocryptine [14]. All other materials were of the highest purity cellophane sheets on BII agar [44] and grown for 2–3 days at 28	C.
commercially available. The cellophane sheets were placed on petri dishes containing 15
ml of lytic solution corresponding to SMac buffer (0.2 M potassium
Methods of Analyses maleate [pH 5.2]) containing 15 mg/ml -D-Glucanase Enzyme (In-
Radioactive determinations were as described [14]. Protein concen- terspex, USA), so that the mycelia faced downwards. The mycelia
trations were determined according to [39]. SDS-polyacrylamide gel could then be easily detached and were incubated for about 2 hr
electrophoresis was performed according to [40]. Autofluorography at 80 rpm and 28	C. The protoplasts were filtered through sterile
of radiolabeled samples in SDS-poylacrylamide gels was as de- filter funnels (POR1 and POR2). They were further pelleted by centrif-
scribed [14]. Immunoblot analyses were performed by standard pro- ugation 10 min at 4500  g, washed twice with STC buffer (0.85 M
cedures. Enzyme assays were based on the ATP-pyrophophate sorbitol, 10 mM Tris, 50 mM CaCl2), and brought to a final concentra-
reaction dependent on D-lysergic acid and amino acids or on en- tion of 108 protoplasts/ml STC. 107 protoplasts were transformed
zyme-thioester formation from dihydrolysergic acid or the relevant as described [22].
amino acid substrates of LPS1 [14]. TLC for separation of alkaloid After 8 hr of regeneration at 28	C, protoplasts were overlaid with
mixtures was performed on silica gel plates using ethyl ace- 10 ml BII/8 containing 100g/ml phleomycin (Cayla, final concentra-
tate:methanol:water (100:5:5, by volume) or ethyl acetate:dimethyl- tion 33 g/ml). Positive transformants were screened by transferring
formamide:ethanol (75:15:5, by volume) [14]. them to 100 g/ml bleomycin selection plates. Due to the inability
of the production strain P1 to sporulate, the purification of the mu-
tants was performed by protoplasting (see above) or hyphal tipMass Spectrometry
Mass spectrometric detection was carried out using an Es- dissection. Phleomycin-resistant transformants carrying a homolo-
gous integration of the replacement construct were identified byquire3000 ion trap instrument (Bruker Daltonik GmbH, Germany)
equipped with a API-ESI interface. Ions were scanned with a scan PCR using primers P2HUX (5-TGAATGCTCCGTAACACCCAATA
3), P2HLX (5-AAAGGCCAAAGAAAATCACG-3) (shown in Figurespeed of 13,000 Da/s. Using ESI in positive ion mode, mass spectra
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5A) for the right flank, P2HUCP (5- CAAGAGGGCGTGCTGAAT-3), pNG5 (1.6 liters of 2 YT medium, 100 g/ml ampicillin, 25 g/ml
kanamycin) were grown at 30	C to an A600 of 0.9 and then inducedP2HLCP (5 GCGGAACTGGCCCTTATCGT 3) for the left flank, and
10–100 ng of genomic DNA. The predicted 1692 bp (right) and 1829 with 0.1 mM isopropylthiogalactoside. Cells were harvested after a
further 14 hr of incubation at 30	C.bp (left) fragments were amplified from DNA of strain cpps2-1. The
lack of the wild-type gene copy in the cpps2 mutants was checked
using the primers P2WUX (5-ACGCCGCAATGCCACTTCAG-3) and Enzyme Purifications
P2HLX (5-AAAGGCCAAAGAAAATCACG-3), which gave rise to a The procedure to isolate LPS1 and LPS2 from extracts of Claviceps
1922 bp fragment with the wild-type strain. Southern analysis was purpurea strains was as described previously. Seven-day-old myce-
performed in order to verify the homologous integration of the re- lia were used in each case, and the amount of starting material was
placement vector. Genomic DNA from knockout mutants and wild- 30 g wet weight [14]. For the purpose of the present work, the first
type was restricted with ClaI, seperated via gel electrophoresis (1%), Ultrogel AcA 34 step was sufficient to show the presence or absence
and transferred to a nylon filter (HybondN, Amersham). The filter of LPS2 in extracts of strain P1 and the cpps2-1 mutant, respec-
was probed with a 3.5 kb SalI fragment from the p63SalI3,5 plasmid. tively [14]. Purification of recombinant LPS2 from E. coli by Ni-NTA
Transcription of cpps2 and cpps2 was tested by Northern analy- matrix was not possible with the hexaHis-LPS2 versions of LPS2
sis. Mycelia from strains P1 and cpps2-1 were incubated at 24	C encoded by cpps2_pNG5 or pps2_pIO4. Therefore, LPS2-30 was
under alkaloid biosynthesis conditions (T25N production medium, chosen for partial purification from E. coli, following some of the
0.5 g/l phosphate, 300 g/l sucrose) for 7 days. The RNA extraction steps of purification of the protein from C. purpurea. The various
was performed according to [24]. The RNA was electrophoretically steps involved cell disintegration by rupture in the French press and
separated and afterwards transferred to a nylon filter. The filter was ammonium sulfate precipitation of the polymin P-cleared superna-
hybridized with a 3.5 kb SalI fragment (p63SalI3,5; cpps2) and a 0.8 tant of cell extract (60% saturation). This was followed by gel filtra-
kb SalI fragment (p21SalI0,8; cpd1) tion on Ultrogel Aca 34 (detection of enzyme activity by the
D-lysergic acid-dependent ATP-pyrophophate exchange). Gel filtra-
tion was followed by two rounds of anion exchange chromatographyEngineering cpps2 for Expression in E. coli as an Amino-
on resource Q and Mono Q (Pharmacia). Finally, enzyme was sub-Terminal HexaHis Fusion Protein (LPS2-32)
jected to gel filtration on Superdex 200 (Figure 7). Buffer conditionsExon 1 in the cpps2 sequence (Genbank accession number
were as described previously [14]. Enzyme activity in all separationsAJ439610) between nt 545 and nt 1054 was engineered via PCR
eluted as a single peak.using genomic cpps2 as template to carry a single SphI site encom-
passing the ATG-start codon and an EcoRV site encompassing the
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